Gene: CDADC1
Official Full Name: cytidine and dCMP deaminase domain containing 1provided by HGNC
Gene Summary: Enables several functions, including cytidine deaminase activity; importin-alpha family protein binding activity; and protein homodimerization activity. Involved in DNA cytosine deamination and cytidine deamination. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25713 | CDADC1 Knockout cell line (HeLa) | Human | CDADC1 | 1:3~1:6 | Negative | Online Inquiry |
KO25714 | CDADC1 Knockout cell line (HCT 116) | Human | CDADC1 | 1:2~1:4 | Negative | Online Inquiry |
KO25715 | CDADC1 Knockout cell line (HEK293) | Human | CDADC1 | 1:3~1:6 | Negative | Online Inquiry |
KO25716 | CDADC1 Knockout cell line (A549) | Human | CDADC1 | 1:3~1:4 | Negative | Online Inquiry |
CDADC1 Gene Knockout Cell Lines are advanced research tools designed to facilitate the in-depth study of the CDADC1 gene, which is implicated in various biological processes and diseases. These genetically modified cell lines have undergone precise gene editing to disrupt the expression of CDADC1, enabling investigators to model the functional consequences of its knockout and understand its role in cellular mechanisms.
The primary function of CDADC1 Gene Knockout Cell Lines is to serve as a valuable platform for assessing gene function, signaling pathways, and cellular responses in a controlled environment. By utilizing techniques such as CRISPR/Cas9 technology, researchers can effectively create loss-of-function mutations, allowing for the investigation of phenotypic changes and the elucidation of gene interactions. These cell lines are integral to the exploration of disease mechanisms, drug responses, and potential therapeutic targets, making them crucial tools in both research and clinical applications.
The scientific importance of these models extends to their capability to provide insights into various conditions such as cancer, metabolic disorders, and genetic syndromes. By studying the altered behavior of CDADC1 knockout cells, researchers can identify novel drug targets, investigate cellular resilience, and understand the molecular pathways affected by CDADC1 deficiency.
One of the standout advantages of our CDADC1 Gene Knockout Cell Lines is their reliability and reproducibility, providing consistent results across experiments. Unlike other gene editing methods that may result in off-target effects or variable knockout efficiency, our cell lines ensure precise disruption of the CDADC1 gene, improving the fidelity of experimental outcomes. Additionally, these cell lines are compatible with various assays, including proliferation, migration, and signaling assays, making them versatile tools in any laboratory setting.
For researchers and clinicians alike, the value of CDADC1 Gene Knockout Cell Lines lies in their ability to accelerate the understanding of gene function and its implications in health and disease. By integrating these knockout models into their research frameworks, scientists can drive innovations in precision medicine and personalized therapies.
As a company dedicated to advancing biological research, we leverage our extensive expertise in genetic engineering and cell line development to provide high-quality products like the CDADC1 Gene Knockout Cell Lines, contributing to transformative discoveries in the field of molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.